Zurex Pharma Obtains $6,000,000 Series C Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=48113180-b6ba-459d-a974-07b7e711d95d
Date
8/15/2016
Company Name
Zurex Pharma
Mailing Address
2113 Eagle Drive Middleton, WI 53562 USA
Company Description
Zurex Pharma, Inc. is a specialty pharma and medical technology company with a novel antimicrobial technology platform. Our company’s mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare acquired infections with a focus on surgical site wounds and catheter-related infections.
Website
http://www.zurex-pharma.com
Transaction Type
Venture Equity
Transaction Amount
$6,000,000
Transaction Round
Series C
Proceeds Purposes
Zurex intends to use the funds to support pivotal Phase III clinical trials of its lead compound and for general corporate and working capital purposes.
M&A Terms
Venture Investor
Undisclosed